Please login to the form below

Not currently logged in
Email:
Password:

Glenmark Pharmaceuticals

This page shows the latest Glenmark Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Indian court blocks generic of Merck's Januvia

Indian court blocks generic of Merck's Januvia

India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.

Latest news

  • Merck wins injunction against Januvia generics in India Merck wins injunction against Januvia generics in India

    A case against another drugmaker that has already launched generic copies of the two drugs - Glenmark Pharmaceuticals - is not due to come to court until next month. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on

  • Merck & Co fails to block generic Januvia in India Merck & Co fails to block generic Januvia in India

    Glenmark Pharmaceuticals from selling a generic version of its Januvia and Janumet diabetes drugs. ... of its price in the US – while Glenmark's versions are sold at a 20-30 per cent discount.

  • Lilly's Strattera patent upheld in US

    Companies looking to capitalise on the loss of patent with their own versions of atomoxetine included Sun Pharmaceutical, Novartis' Sandoz unit, Aurobindo Pharma and Glenmark Pharmaceuticals.

  • Glenmark to launch anti-diarrhoea drug

    Glenmark Pharmaceuticals is preparing to launch novel anti-diarrhoea drug Crofelemer following successful phase III trials. ... Glenmark Pharmaceuticals has announced it is preparing to launch novel anti-diarrhoea drug Crofelemer following successful

  • Multi-pronged approach

    Exalgo (Covidien). Moderate-to-severe pain in opioid tolerant patients. US. Prasugrel . Aplet (Glenmark Pharmaceuticals). ... Glaucoma and ocular hypertension. South Korea. Freeze-dried varicella vaccine. (Hard to Treat Diseases)  . Prevention of

More from news
Approximately 3 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics